Selected article for: "flow rate and oxygen flow rate"
Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
    • ID: roslkxeq_55
    Snippet: Respiratory failure due to cardiogenic pulmonary edema secondary to MVD is a very common disease in dogs; in this study, CPAP-helmet interface was a valid alternative to oxygen flow-by therapy. Though clinical improvement was similar in the first 30 min, CPAP-helmet reduced the need for butorphanol administration, quickened both clinical and radiographic signs of pulmonary edema improvement and showed a decrease of the mortality rate compared to .....
    Document: Respiratory failure due to cardiogenic pulmonary edema secondary to MVD is a very common disease in dogs; in this study, CPAP-helmet interface was a valid alternative to oxygen flow-by therapy. Though clinical improvement was similar in the first 30 min, CPAP-helmet reduced the need for butorphanol administration, quickened both clinical and radiographic signs of pulmonary edema improvement and showed a decrease of the mortality rate compared to oxygen flow-by. CPAP-helmet was well tolerated by all dogs.

    Search related documents:
    Co phrase search for related documents
    • butorphanol administration and oxygen flow: 1
    • clinical improvement and common disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical improvement and edema improvement: 1
    • clinical improvement and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical improvement and mortality rate decrease: 1, 2
    • clinical improvement and oxygen flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical improvement and pulmonary edema improvement: 1
    • clinical improvement and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical improvement and therapy oxygen flow: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • common disease and dog common disease: 1
    • common disease and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • common disease and oxygen flow: 1, 2, 3, 4, 5
    • common disease and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • common disease and therapy oxygen flow: 1, 2
    • cpap helmet and mortality rate: 1, 2
    • cpap helmet and oxygen flow: 1, 2, 3, 4
    • cpap helmet and respiratory failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cpap helmet interface and respiratory failure: 1
    • edema improvement and pulmonary edema improvement: 1, 2, 3